Kim Choy Yap serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kim Choy Yap has executed 8 insider transactions totaling $770.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 5, 2025 involved selling 28,540 shares valued at $48.5K.
Kim Choy Yap currently holds 467,535 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kim Choy Yap has been a net seller of CYCC stock. They have purchased $0 and sold $770.5K worth of shares.
Kim Choy Yap's most recent insider trade was on Nov 5, 2025, when they sold 28,540 shares at $1.70 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 30, 2025 | BGMS | $203.2K | Sale | 112,260 | $1.81 | Discretionary |
| Oct 29, 2025 | BGMS | $202.7K | Sale | 110,749 | $1.83 | Discretionary |
| Oct 28, 2025 | BGMS | $24.0K | Sale | 13,111 | $1.83 | Discretionary |
| Oct 27, 2025 | BGMS | $254.9K | Sale | 120,250 | $2.12 | Discretionary |
| Oct 24, 2025 | BGMS | $37.2K | Sale | 19,595 | $1.90 | Discretionary |
| Sep 4, 2025 | CYCC | $0 | Other | 186,465 | $N/A | Discretionary |